BeiGene Ltd. (BGNE) Dividend History
BeiGene Ltd is a clinical-stage biopharmaceutical company engaged in the discovery & development of molecularly targeted & immuno-oncology drugs for the treatment of cancer. Its product includes BGB-3111, BGB-283 and BGB-290 and one immuno-oncology agent.
Last update 12/14/2019
Dividend Yield Summary
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | |
| Dividends | - | - | - | - | - | - |
| Average Price | - | - | 29.64 | 60.57 | 153.88 | 138.76 |
| Yield | - | - | - | - | - | - |
Dividend History
No history of dividends
| Date | Amount Per Share | Note |